Lung Ultrasound in the Early Detection of Postoperative Pulmonary Complications After Esophagectomy
OESOLUS
2 other identifiers
observational
274
1 country
1
Brief Summary
The perioperative management of esophageal cancer has evolved considerably in recent years. Over the last 30 years, postoperative mortality has been steadily decreasing. However, respiratory morbidity remains high (30-40%). This is due to the procedure itself requiring a thoracic approach and intraoperative unipulmonary ventilation. The postoperative pulmonary complications (PPCs) are multiple: bronchial congestion, atelectasis, pneumopathy, acute respiratory failure, liquid pleural effusion, pneumothorax. In general, prevention and early treatment are aimed at limiting the evolution towards acute respiratory failure requiring ventilatory assistance. Chest radiography is essential for the presumptive diagnosis of pneumopathy in particular, but the interpretation of the images may be difficult. Thoracic computed tomography (CT) is the gold standard because it is sensitive and can discriminate among differential diagnoses. This is difficult to perform: it requires intra-hospital transport of patient, who is often in acute respiratory failure, and the availability of an examination area. Lung ultrasound is used at the bedside for diagnosis of lung infection in intensive care unit. This has a sensitivity close to thoracic CT and has the advantage of being feasible at any time, does not require transport of the patient and is not irradiating. Lung ultrasound allows early detection of the need for ventilatory support in postoperative major abdominal surgery . In addition, the sensitivity of lung ultrasound is close to that of CT, allowing this examination to be relied upon. The main objective of the study is to determine the role of lung ultrasound (LUS) in the prediction of postoperative pulmonary complications within one hour after extubation. The secondary objectives are to determine the performance of lung and diaphragmatic ultrasound (DUS) on postoperative day 1 and to establish a predictive model integrating LUS, DUS, and clinical variables to improve early identification of patients at risk of postoperative pulmonary complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 7, 2022
CompletedFirst Posted
Study publicly available on registry
July 12, 2022
CompletedStudy Start
First participant enrolled
August 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2025
CompletedJanuary 15, 2026
January 1, 2026
2.7 years
July 7, 2022
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Area under the curve (AUC) of the Lung ultrasound score
at Day 0 (within 1 hour of tracheal extubation)
Secondary Outcomes (10)
Area under the curve (AUC) of the Lung ultrasound score at Day 1
Day 1
Diaphragmatic excursion is measured via subcostal diaphragmatic ultrasound performed during the patient's clinical examination
at Day 0, Day 1 and Day 3
The presence of condensations on pleuropulmonary ultrasound in the ICU
at Day 0, Day 1 and Day 3
The presence of pleural effusion at D0, D1 or D3
at Day 0, Day 1 and Day 3
Complications according to the Dindo-Clavien classification
at Day 7
- +5 more secondary outcomes
Eligibility Criteria
Prospective cohort study of esophagectomy patients in a tertiary hospital
You may qualify if:
- Thoracic Esophagectomy
You may not qualify if:
- Emphysema Death during surgery Refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hop Claude Huriez Chu Lille
Lille, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cédric CIRENEI, MD,PhD
University Hospital, Lille
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2022
First Posted
July 12, 2022
Study Start
August 22, 2022
Primary Completion
April 30, 2025
Study Completion
April 30, 2025
Last Updated
January 15, 2026
Record last verified: 2026-01